References:

1. Burger, HG. Androgen Production in Women. Fertil Steril 2002;77(4 Suppl):S3-S5.

2. Maclean H, Warne G, Zajac J. Localization of functional domains in the androgen receptor. J Steroid Biochem Mol Biol 1997;62:233-42.

3. Traish AM, Kim N, Min K, et al. Role of Androgens in female genital sexual arousal: receptor expression, structure and function. Fertil Steril 2002;77(4):S11-S18.

4. Keller E, Ershler W, Chang C. The androgen receptor: a mediator of diverse responses. Front Biosci 1996;1:d59-71.

5. Lamb D, Weigel N, Marcelli M. Androgen receptors and their biology. Vitam Horm 2001;62:199-230.

6. Lobacarro J, Poujol N, Chiche L, et al. Molecular modeling and in vitro investigations of the human androgen receptor DNA-binding domain: application for the study of two mutations. Mol Cell Endocrinol 1996;116:137-147.

7. Mckenna N, Lanz R, O'Malley B. Nuclear Receptor coregulators: cellular and molecular biology. Endocr Rev 1999;20:321-344.

8. Dimitrakakis C, Zhou J, Bondy CA. Androgens and mammary growth and neoplasia. Fertil Steril 2002;77(suppl 4):S26-S33.

9. Wilburt D, Griffin J, Wilson J. Characterization of the cytosol androgen receptor of the human prostate. J Clin Endocrinol Metab 1983;56:113-120.

10. Wilson E, French F. Binding properties of androgen receptors. Evidence for identical receptors in rat testis, epididymis, and prostate. J Biol Chem 1976;251:5620-5629.

11. Zhou Z, Lane M, Kemppainen J, et al. Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Mol Endocrinol 1995;9:208-218.

12. Modugno F. Ovarian Cancer and Polymorphisms in the Androgen and Progesterone Receptor Genes: A HuGE Review. Am J Epidem 2004;159(4):319-335.

13. Lobo RA. Androgens in postmenopausal women: production, possible role, and replacement options. Obstet Gynecol Surv 2001;56(6):361-376.

14. Burger H, Dudley EC, Cui J, et al. A prospective longitudinal study of serum testosterone dehydroepiandrosterone sulphate and sex hormone binding globulin levels through the menopause transition. J Clin Endocrinol Metab 2000;85:2832-2938.

15. Labrie F, Belanger A, Cusan L, et al. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997;82(8):2396-2402.

16. Lasley BL, Santoro N, Randolf JF, et al. The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity. J Clin Endocrinol Metab 2002;87:3760-3767.

17. Longcope C. Metabolic and blood production rates of estrogen in postmenopausal women. Am J Obstet Gynecol 1971;111:778-781.

18. Vermuelen A. The hormonal activity of the postmenopausal ovary. J Clin Endocrinol Metab 1976;42:247-253.

19. Adashi EY. The climacteric ovary as a functional gonadotropin-driven androgen-producing gland. Fertil Steril 1994;62:20-27.

20. Judd HL, Lucas WE, Yen SCS. Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab 1974;39:1020.

21. Dowsett M, Cantwell B, Lal A, et al. Suppression of postmenopausal ovarian steroidogenesis with the lutenizing hormone-releasing hormone agonist Goserelin. J Clin Endocrinol Metab 1988;66:672-677.

22. Sluijmer AV, Heineman MJ, De Jong FH, et al. Endocrine activity of the postmenopausal ovary: the effects of pituitary down-regulation and oophorectomy. J Clin Endocrinol Metab 1995;80:2163-2167.

23. Couzinet B, Meduri G, Lecce MG, et al. The postmenopausal ovary is not a major androgen-producing gland. J Clin Endocrinol Metab 2001;86:5060-5066.

24. Erickson GF, Magoffin DA, Dyer C, et al. The ovarian androgen producing cells: a review of structure/function relationships. Endocr Rev 1985;6:371-398.

25. Heineman MJ, Sluijmer AV, Ever JLH. Utero-ovarian vein blood sampling in postmenopausal women. Fertil Steril 1993;60:184-186.

26. Rinaudo P, Strauss JF. Endocrine function of the postmenopausal ovary. Endocr Metabol Clin 2004;33(4):661-674.

27. Simon JA. Estrogen Replacement Therapy: effects on the endogenous androgen milieu. Fertil Steril 2002;77(4):S77-S82.

28. Labrie F, Luu V, Labrie C, et al. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr Rev 2003;24:152-182.

29. Simpson ER. Aromatization of androgens in women: current concepts and findings. Fertil Steril 2002;77(suppl 4):S6-S10.

30. Ukkola O, Rankinen T, Gagnon J, et al. A genome-wide scan for steroids and SHBG levels in black and white females: the HERITAGE Family Study. J Clin Endocrinol Metab 2002;87:3708-3720.

31. Laan E, Van Lunsen RH. Hormones and sexuality in postmenopausal women: a psychophysiological study. J Psychosom Obstet Gynaecol 1997;18:126-133.

32. Sarrel PM. Sexuality and Menopause. Obstet Gynecol 1990;75(Suppl):S26-30.

33. Sarrel PM. Ovarian hormones and vaginal blood flow using laser doppler velocimetry to measure effects in a clinical trial in postmenopausal women. Int J Impot Res 1998;10:S91-S93.

34. Simon JA, Klaiber E, Wiita B, et al. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women. Menopause 1999;6:138-146.

35. Sarrel PM. Effects of hormone replacement therapy on sexual psychophysiology and behavior in postmenopause. J Womens Health Gend Based Med 2000;9(Suppl 1):S25-S32.

36. Stenberg A, Heimer G, Ulmsten U. The prevalence of urogenital symptoms in postmenopausal women. Maturitas 1995;22(Suppl):S17-S20.

37. Bulun SE, Simpson ER. Competitive reverse transcription-polymerase chain reaction analysis indicates that levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs and abdomen of women increase with advancing age. J Clin Endocrinol Metab 1994;78:428-432.

38. Longcope C, Baler S. Androgen and estrogen dynamics: relationships with age, weight and menopause status. J Clin Endocrinol Metab 1993;76:601-604.

39. Laughlin GA, Barrett-Connor E, Kritz-Silverstein D, et al. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab 2000;85(2):645-651.

40. Tazuke S, Shaw KT. Exogenous estrogen and endogenous sex hormones. Medicine 1992;71:44-51.

41. Judd HL. Hormonal dynamics associated with the menopause. Clin Obstet Gynecol 1976;19:775-788.

42. Sarrel PM. Psychosexual effects of menopause: role of androgens. Am J Obstet Gynecol 1999;180:S319-S324.

43. Sherwin BB. Hormones, mood, and cognitive functioning in postmenopausal women. Obstet Gynecol 1996;87:S20-S26.

44. Avis N, Brambilla D, Mckinlay S, et al. A longitudinal analysis of the association between menopause and depression: results from the Massachusetts Women's Health Study. Ann Epidemiol 1994;4:15-21.

45. Sarrel P. Androgen deficiency: menopause and estrogen-related factors. Fertil Steril 2002;77(4):S63-S67.

46. Sherwin BB, Gelfand MM. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med 1987;49:397-409.

47. Sarrel P. Sexuality and Menopause. Obstet Gynecol 1990;75 (Suppl):S26-S30.

48. Sourla A, Flamand M, Belanger A, et al. Effect of dehydroepiandrosterone on vaginal and uterine histomorphology in the rat. J Steroid Biochem Mol Biol 1998;66:137-49.

49. Kennedy T, Armstrong D. Induction of vaginal mucification in rats with testosterone and 17beta-hydroxy-5alpha-androstan-3-one. Steroids 1976;27:423-30.

50. Hodgins M, R S, Mackie R, Maclean A. An immunohistochemical study of androgen, oestrogen and progesterone receptors in the vulva and vagina. Brit J Obstet Gynaecol 1998;105:216-222.

51. Berman J, Almeida F, Jolin J, et al. Correlation of androgen receptors, aromatase, and 5-alpha reductase in the human vagina with menopausal status. Fertil Steril 2003;79(4):925-931.

52. Ho M, Bhatia N, Bhasin S. Anabolic effects of androgens on muscles of female pelvic floor and lower urinary tract. Curr Op Obstet Gynecol 2004;16:405-409.

53. Nnodim J. Quantitative study of the effects of denervation and castration on the levator ani muscle of the rat. Anat Rec 1999;255:324-333.

54. Nnodim J. Testosterone modifies satellite cell activation in denervated rat levator ani muscle. Anat Rec 2001;263:19-24.

55. Monks D, O'bryant E, Jordan C. Androgen receptor immunoreactivity in skeletal muscle: enrichment at the neuromuscular junction. J Comp Neurol 2004;473:59-72.

56. Rosenweig B, Bolina P, Birch L, et al. Location and concentration of estrogen, progesterone and androgen receptors in the bladder and urethra of the rabbit. Neurourol Urodyn 1995;14:87-96.

57. Salmi S, Santti R, Gustafsson J, et al. Co-localization of androgen receptor with estrogen receptor beta in the lower urinary tract of the male rat. J Urology 2001;166:674-677.

58. Copas P, Bukovsky A, Asbury B, et al. Estrogen, Progesterone, and Androgen Receptor Expression in Levator Ani Muscle and Fascia. J Women's Health Gen-Based Med 2001;10(8):785-795.

59. Ewies A, Thompson J, Al-Azzawi F. Changes in gonadal steroid receptors in the cardinal ligaments of prolapsed uteri; immunohistomorphometric data. Hum Reprod 2004;19:1622-1628.

60. Bai S, Jung B, Chung B, et al. Relationship between urinary profile of the endogenous steroids and postmenopausal women with stress urinary incontinence. Neurourol Urodyn 2003;22:198-205.

61. Maia H, Maltez A, Fahel P, et al. Detection of testosterone and estrogen receptors in the postmenopausal endometrium. Maturitas 2001;38:179-188.

62. Tada A, Sasaki H, Nakamura J, et al. Aromatase activity and the effect of estradiol and testosterone on DNA synthesis in endometrial carcinoma cell lines. J Steroid Biochem Mol Biol 1993;44:661-666.

63. Lea O, Kvinnsland S, Thorsen T. Improved measurement of androgen receptors in human breast cancer. Cancer Res 1989;49:7162-7167.

64. Davis S. Androgen Replacement in women: a commentary. J Clin Endocrinol Metab 1999;84:1886-1891.

65. Birrell S, Hall R, Tilley W. Role of the Androgen Receptor in Human Breast Cancer. J Mamm Gland Biol Neoplasia 1998;3(1):95-103.

66. Recchione C, Venturelli E, Manzari A, et al. Testosterone, dihydrotestosterone, and oestradiol levels in postmenopausal breast cancer tissues. J Steroid Biochem Mol Biol 1995;52:541-546.

67. Bryan RM, Mercer RJ, Rennie GC, et al. Androgen receptors in breast cancer. Cancer 1984;54:2436-2440.

68. Tormey D, Lippman M, Edwards B, et al. Evaluation of Tamoxifen doses with and without fluoxymesterone in advanced breast cancer. Ann Intern Med 1983;98:139-144.

69. Notelovitz M. Androgen effects on bone and muscle. Fertil Steril 2002;77(4):S34-S41.

70. Aloia J, McGowan D, Vaswani A, et al. The relationship of menopause to skeletal and muscle mass. Am J Clin Nutr 1991;53:1378-1383.

71. Phillips S, Rook K, Siddle N, et al. Muscle weakness in women occurs at an earlier age than men, but strength is preserved by hormone replacement therapy. Clin Sci 1993;84:94-98.

72. Sinha-Hakim I, Artaza J, Woodhouse L, et al. Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. Am J Physiol Endocrinol Metab 2002;283:E154-E164.

73. Sinha-Hakim I, Roth S, Lee M, et al. Testosterone-induced muscle hypertrophy is associated with an increase in satellite cell number in healthy young men. Am J Physiol Endocrinol Metab 2003;285:E197-E205.

74. Bhasin S, Taylor W, Singh R, et al. The mechanism of androgen effects on body composition: mesenchymal pluripotent cell as the target of androgen action. J Gerontol 2003;58A:1103-1110.

75. Liu P, Death A, Handelsman D. Androgens and Cardiovascular Disease. Endocr Rev 2003;24(3):313-340.

Additional resources on female sexuality are available from MayoClinic.com:

http://www.mayoclinic.com/health/kegel-exercises/WO00119
http://www.mayoclinic.com/health/sexual-health/HA00035
http://www.mayoclinic.com/health/womens-health/WO00110
http://www.mayoclinic.com/health/sexual-health/HQ01363